The governor during TCB’s inaugural years doesn’t have much good to say about state governance today.
TCB Q&A
The Minneapolis-based medical cannabis company plans to wrap its Series D round in the coming weeks.
As the future of newspapers becomes more tenuous, Strib Publisher Mike Klingensmith talks about the national media climate, Super Bowl, and future of print and digital media.
Minneapolis Public Schools superintendent Ed Graff reflects on his progress.
The former leader of Blue Cross and Blue Shield of Minnesota discusses diversification and the future.
The Minnesota Business Partnership’s executive director is tackling a workforce shortage, achievement gap and business competition threats.
A decade into her tenure, Kaywin Feldman discusses disruption, reinvention and the dangers of relying exclusively on data.
Minneapolis’ new mayor on his early agenda and healing the city’s relationship with business.
Jim Finley, Minnesota's top official for finding jobs for veterans, discusses the state's progress on hiring more veterans and what improvements still need to be made.
The former chief executive of Vascular Solutions beat federal charges
of off-label use. Now he discusses his next move, and why government
oversight is hampering the medical device industry.
With a downturn in donations, TCB asks CEO Sarah Caruso how the nonprofit's business model is adapting and what roles it plays beyond grantmaking.
With just over a year left in his second term, we ask Governor Mark Dayton questions currently on the mind of business.
Unwrap five stories to understand why your company
is spending more than ever on health care.
GrantAdvisor aims to improve philanthropic practice through user feedback.
THE LATEST DISCOVERIES FROM PROVIDERS, PRODUCT DEVELOPERS AND PAYERS. | EDITED BY KATE LERETTE
Part of getting ahead in the entrepreneurial space is speaking the language.
The Minneapolis Fed President on banking, bailouts, blind spots, Jamie Dimon and Donald Trump.
A Q&A with MnDOT Commissioner Charlie Zelle